Journals / Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2019 / Cilt: 9 - Sayı: 3

D-allulose (D-psicose) in Carbohydrate and Lipid Metabolism

Karbonhidrat ve Yağ Metabolizmasında D-alluloz (D-psikoz)

Pages
188–195
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Reducing absorption of oral monosaccharides can be thought of as an alternative treatment modality with obesity and lifestyle changes due to its effects such as suppressing glucose oxidation while increasing fatty acid oxidation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Due to changing living conditions, the incidence of obesity and endocrine diseases related to obesity has increased.
📊
Key Findings & Data:Dallulose is the 3rd carbon epimer of fructose and is rarely found in nature.
💡
Conclusion & Impact:Reducing absorption of oral monosaccharides can be thought of as an alternative treatment modality with obesity and lifestyle changes due to its effects such as suppressing glucose oxidation while increasing fatty acid oxidation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Due to changing living conditions, the incidence of obesity and endocrine diseases related to obesity has increased. In addition to lifestyle changes, alternative treatment options are being sought in the prevention of these diseases. Dallulose is the 3rd carbon epimer of fructose and is rarely found in nature. D-allulose shows activity through various mechanisms such as strong antioxidant effects, inhibitory activity against intestinal digestive enzymes, translocation of glucokinase from hepatic nucleus to cytoplasm and competitive transport by glucose through intestinal mucosa. In addition, there are antihyperlipidemic, antihypertriglyceridemic effects related to lipid metabolism. Toxicity studies on D-allulose-related rats did not show any side effects and were considered safe. Reducing absorption of oral monosaccharides can be thought of as an alternative treatment modality with obesity and lifestyle changes due to its effects such as suppressing glucose oxidation while increasing fatty acid oxidation.

Özet

Değişen yaşam koşulları nedeniyle obezite ve obezite ile ilişkili endokrin hastalıkların görülme sıklığı artmıştır. Buhastalıkların önlenmesinde yaşam tarzı değişikliklerine ek tedavi seçenekleri aranmaya başlamıştır. D-alluloz fruktozun3. karbon epimeridir ve doğada nadiren bulunmaktadır. D- alluloz, güçlü antioksidan etkileri, bağırsak sindirimenzimlerine karşı inhibe edici aktivitesi, hepatik çekirdekten sitoplazmaya glukokinazın translokasyonu ve intestinalmukoza yoluyla glukozla rekabetçi transport gibi çeşitli mekanizmalar yoluyla aktivite göstermektedir. Ayrıca, yağlarınmetabolizması ile ilgili olarak antihiperlipidemik, antihipertrigliseridemik etkileri de bulunmaktadır. D-alluloz ile ilgiliratlar üzerinde yapılan toksisite çalışmalarında herhangi bir yan etkisi gösterilmemiş ve güvenli olarak kabul edilmiştir.Oral yol ile alınan monosakkaritlerin emilimini azaltması, yağ asidi oksidasyonunu arttırırken, glukoz oksidasyonunubaskılaması gibi etkilerinden dolayı obezite ve ilişkili hastalıkların tedavisinde yaşam tarzı değişikliği ile beraberalternatif bir tedavi yöntemi olarak düşünülebilir.

🔖

Cite This Article

ÖZGÜR, M., UÇAR, A. (2022). D-allulose (D-psicose) in Carbohydrate and Lipid Metabolism. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 9 - Sayı: 3, 188–195. https://ajindex.com/articles/494752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. TC Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Türkiye sağlıklı beslenme ve hareketli hayat programı. Ankara: Sağlık Bakanlığı; 2013
  2. Bereket A, Atay Z. Current status of childhood obesity and its associated morbidities in Turkey. Journal of Clinical Research in Pediatric Endocrinology. 2012; 4(1): 1-7
  3. Yeşilkaya E, Cinaz P, Andıran N, Bideci A, Hatun Ş, Sarı E ve ark. First report on the nationwide incidence and prevalence of Type 1 diabetes among children in Turkey. Diabetic Medicine. 2017; 34(3): 405-10
  4. TURDEP Çalışma Grubu. TURDEP-2 sonuçlarının özetleri. Satman I
  5. TEMD Kongresi; 2010; Antalya
  6. Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Current Opinion in Lipidology. 2008; 19(1): 63-8
  7. Borges M C, Louzada M L, de Sá T H, Laverty AA, Parra DC, Garzillo JMF, et al. Artificially sweetened beverages and the response to the global obesity crisis. PLoS medicine. 2017; 14(1): e1002195
  8. WHO. Noncommunicable diseases and their risk factors. London: The Lancet Global Health; [Updated: 5 Sep 18; Cited: 26 Sep 18] Available from:
  9. Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. Journal of Education and Health Promotion. 2014: 3(1): 1-8. doi: 10.4103/2277-9531.127541
  10. Nagata Y, Mizuta N, Kanasaki A, Tanaka K. Rare sugars, d-allulose, d-tagatose and d-sorbose, differently modulate lipid metabolism in rats. Journal of the Science of Food and Agriculture. 2018; 98(5): 2020-6
  11. Yan Tang S. Rare Sugars: Applications and Enzymatic Production. Biocatalysis and Biotransformation. 2012; 1(2): 363-8
  12. Matsuo T, Izumori K. Effects of dietary D-psicose on diurnal variation in plasma glucose and insulin concentrations of rats. Bioscience, Biotechnology, and Biochemistry. 2006; 70(9): 2081-5
  13. Hossain M A, Kitagaki S, Nakano D, Nishiyama A, Funamoto Y, Matsunaga T. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long–Evans Tokushima Fatty (OLETF) rats. Biochemical and Biophysical Research Communications. 2011; 405(1): 7-12. 13.Iida T, Yamada T, Hayashi N, Okuma K, Izumori K, Ishii R. Reduction of abdominal fat accumulation in rats by 8-week ingestion of a newly developed sweetener made from high fructose corn syrup. Food Chemistry. 2013; 138(2-3): 781-5
  14. Hossain A, Yamaguchi F, Matsuo T, Tsukamo